Key facts
- Chambertech’s last known valuation is $7.9M (Sep 2025).
- It has raised $930K; the latest was Early Stage VC ($560K) in Sep 2025.
- Notable investors include WCS Nominees, Oxford Technology Management.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Chambertech
- ·The full record, as it builds
Funding rounds
No funding rounds for Chambertech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chambertech
Operator of a medical technology intended to reduce the duration and increase the efficiency of treating heart arrhythmia. The company offers minimally invasive treatment methods and advanced cardiac monitoring tools, enabling patients with arrhythmia to receive faster, more effective care.
- Sector
- Healthcare
- HQ
- Richmond, United Kingdom
- Founded
- 2022
- Employees
- 4
- Website
- chambertech.co.uk/
- Ownership
- Privately Held (backing)
Chambertech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chambertech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chambertech in its N-PORT filings yet. We sweep new filings monthly.